Allworth Financial LP Reduces Holdings in Aflac Incorporated (NYSE:AFL)

Allworth Financial LP reduced its stake in Aflac Incorporated (NYSE:AFL) by 0.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 31,401 shares of the financial services provider’s stock after selling 145 shares during the period. Allworth Financial LP’s holdings in Aflac were worth $3,275,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Spinnaker Trust increased its position in shares of Aflac by 2.7% in the 3rd quarter. Spinnaker Trust now owns 3,620 shares of the financial services provider’s stock valued at $405,000 after purchasing an additional 95 shares during the last quarter. Phillips Wealth Planners LLC lifted its stake in shares of Aflac by 1.5% in the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock worth $662,000 after acquiring an additional 100 shares in the last quarter. Raleigh Capital Management Inc. increased its position in shares of Aflac by 23.2% in the 4th quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock worth $55,000 after purchasing an additional 100 shares during the last quarter. New Century Financial Group LLC increased its stake in Aflac by 2.5% during the third quarter. New Century Financial Group LLC now owns 4,198 shares of the financial services provider’s stock valued at $469,000 after purchasing an additional 101 shares during the last quarter. Finally, Covestor Ltd raised its position in shares of Aflac by 41.8% during the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after purchasing an additional 107 shares during the period. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares in the company, valued at $23,018,701.20. This represents a 10.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.90% of the company’s stock.

Aflac Price Performance

Shares of AFL opened at $103.46 on Tuesday. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12-month low of $78.38 and a 12-month high of $115.50. The stock has a market cap of $57.48 billion, a P/E ratio of 10.78, a P/E/G ratio of 2.10 and a beta of 0.99. The business’s fifty day moving average is $104.18 and its 200 day moving average is $107.25.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Sell-side analysts anticipate that Aflac Incorporated will post 6.95 earnings per share for the current fiscal year.

Aflac Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Wednesday, February 19th will be paid a dividend of $0.58 per share. This is a boost from Aflac’s previous quarterly dividend of $0.50. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date of this dividend is Wednesday, February 19th. Aflac’s dividend payout ratio is presently 20.83%.

Analyst Ratings Changes

AFL has been the topic of several research analyst reports. Barclays lowered their target price on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, February 7th. Wells Fargo & Company boosted their target price on Aflac from $103.00 to $104.00 and gave the company an “equal weight” rating in a research note on Tuesday, January 14th. Evercore ISI cut their price target on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a report on Wednesday, December 4th. Piper Sandler lowered their price target on Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a report on Friday, February 7th. Finally, Keefe, Bruyette & Woods lowered their target price on Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a report on Wednesday, February 12th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Aflac currently has a consensus rating of “Hold” and a consensus price target of $103.00.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.